Bastide Le Confort Medical SA

As of December 31, 2025, Bastide Le Confort Medical SA carries a market capitalization of 177.60M, placing it among publicly traded companies globally. Its enterprise value stands at 475.96M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bastide Le Confort Medical SA's next confirmed earnings release is scheduled for March 24, 2027.

As of December 31, 2025, Bastide Le Confort Medical SA has 7.31M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Bastide Le Confort Medical SA maintains a current ratio of 1.16, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Bastide Le Confort Medical SA's stock has declined approximately 19.83% over the past 52 weeks. The 50-day moving average sits at 21.21, while the 200-day moving average is 23.81.

As of December 31, 2025, Bastide Le Confort Medical SA holds 25.47M in cash and equivalents against 324.13M in total debt, resulting in a net debt position of 244.32M. Total book value stands at 102.75M, with working capital of 26.12M providing operational flexibility.

Bastide Le Confort Medical SA's most recent stock split took place on December 19, 2007 with a 1:3 split ratio.